Marguerre
Ann-Kathrin Marguerre, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20150126363 | Agroformulation comprising copolymer of acrylic acid, poly(alkylene glycol) (meth)acrylate, and alkyl (meth)acrylate - The present invention provides a composition comprising a pesticide and a copolymer, which contains in polymerized form acrylic acid and/or methacrylic acid (monomer A); a mono C | 05-07-2015 |
Wolfgang Marguerre, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20100145021 | PROCESS FOR ENHANCING PROTEIN RECOVERY YIELDS - A process for enhancing the recovery yield of proteins, especially plasma proteins, from sources containing the proteins, wherein the sources containing the proteins are frozen at temperatures of ≦−70° C., and the proteins from a frozen source after thawing are further processed in a per se known manner. | 06-10-2010 |
20110104298 | Universally applicable virus inactivated blood plasma produced from portions of non-Caucasians plasma - A blood plasma for human use pooled from donors which belong to 10% or more to a non-Caucasian population, the plasma obtainable by mixing blood or blood plasma of blood groups A and B, optionally AB without admixing substantial amounts of blood or blood plasma of blood group 0 characterized in that | 05-05-2011 |
Wolfgang Marguerre, Helinborg SE
Patent application number | Description | Published |
---|---|---|
20110008459 | Universally applicable blood plasma - A universally applicable blood plasma obtainable by a process comprising the steps of mixing blood or blood plasma of blood groups A and B optionally blood or blood plasma of blood group AB without admixing substantial amounts of blood or blood plasma derived from blood group 0. | 01-13-2011 |
Wolfgang Marguerre, Helingborg SE
Patent application number | Description | Published |
---|---|---|
20090092678 | Universally applicable blood plasma - A universally applicable blood plasma obtainable by a process comprising the steps of mixing blood or blood plasma of blood groups A and B optionally blood or blood plasma of blood group AB without admixing substantial amounts of blood or blood plasma derived from blood group 0. | 04-09-2009 |